As of 2026-05-26, the Intrinsic Value of Guangdong Kanghua Healthcare Co Ltd (3689.HK) is 7.22 HKD. This 3689.HK valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 1.92 HKD, the upside of Guangdong Kanghua Healthcare Co Ltd is 275.90%.
The range of the Intrinsic Value is 5.52 - 10.73 HKD
Based on its market price of 1.92 HKD and our intrinsic valuation, Guangdong Kanghua Healthcare Co Ltd (3689.HK) is undervalued by 275.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 5.52 - 10.73 | 7.22 | 275.9% |
| DCF (Growth 10y) | 6.46 - 12.51 | 8.44 | 339.4% |
| DCF (EBITDA 5y) | 8.47 - 12.61 | 10.10 | 425.9% |
| DCF (EBITDA 10y) | 8.45 - 13.45 | 10.41 | 442.1% |
| Fair Value | 8.58 - 8.58 | 8.58 | 346.99% |
| P/E | 4.63 - 8.67 | 6.58 | 242.5% |
| EV/EBITDA | 5.06 - 7.17 | 6.33 | 229.6% |
| EPV | 2.69 - 4.75 | 3.72 | 93.8% |
| DDM - Stable | 2.13 - 5.70 | 3.92 | 104.0% |
| DDM - Multi | 2.52 - 5.78 | 3.57 | 85.7% |
| Market Cap (mil) | 642.03 |
| Beta | 0.05 |
| Outstanding shares (mil) | 334.39 |
| Enterprise Value (mil) | 749.58 |
| Market risk premium | 5.98% |
| Cost of Equity | 8.84% |
| Cost of Debt | 4.85% |
| WACC | 6.97% |